Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
18
NCT04094857
Phase 1 Study of HBN-1
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 30, 2019
Completion: Dec 31, 2020